Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Gilead files NDA for new cidofovir formulation

Jan. 7, 1997

Fujisawa reveals antibacterial series

Jan. 7, 1997

Kaken describes novel antibacterial agents

Jan. 7, 1997

Yale receives grant from Vion

Jan. 3, 1997

Novel cephalosporins reported by Japanese investigators

Jan. 3, 1997

Once-daily oral antibiotic from RPR cleared by FDA

Jan. 2, 1997

Mitotix reports antiviral/anticancer antisense constructs

Jan. 2, 1997

Bayer antibacterial cleared for wider use by FDA

Dec. 31, 1996

FDA clears oral monotherapy for PID

Dec. 31, 1996

New cephalosporins from LG Chemical

Dec. 30, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...